A higher dose of the antibiotic rifampicin does not improve survival rates for patients with tuberculous meningitis. This ...

The FDA has approved GSK’s Exdensur (depemokimab-ulaa) as an add-on maintenance therapy for adolescents and adults with severe asthma characterized by an eosinophilic phenotype. 1 ...

Extended-release buprenorphine is approved as a once-monthly subcutaneous injection for the treatment of moderate-to-severe ...

The CDC has officially updated its immunization schedule to reflect its Advisory Committee on Immunization Practices’ ...

The CDC said it is still reviewing a separate ACIP recommendation related to doses administered after the birth-dose period.

People aged 80 and older with a common type of lymphoma can take a half-dose of chemotherapy and be cured or significantly extend their survivorship with fewer toxic side effects, a new study shows.

The UK Health Security Agency has issued an important reminder that these medications don't work for flu and colds ...

Brits have been warned not to take a common pill for the flu or a cold. The UK Health Security Agency (UKHSA) issued an ...

Depemokimab-ulaa (Exdensur) is approved for severe asthma with an eosinophilic phenotype, offering protection with just two ...

Stanford researchers identify two proteins that cause rare heart inflammation after COVID-19 vaccination, offering insights ...

The FDA has approved Exdensur depemokimab-ulaa as an add-on maintenance therapy for severe asthma in patients aged 12 and older, supported by Phase III SWIFT trial data showing significant reductions ...

Learn more about what to expect if you’ve been prescribed this weight loss medication to help treat this chronic liver condition.